CUE
Cue Biopharma, Inc. · Healthcare
Director Peter A Kiener sold $362K of Cue Biopharma, Inc.
Sold$361,690
$17.93Price
20,176Shares
−100%Stake
What CUE did after the filing
- The stock from Wed, Nov 17 close, $485.10
- −30.1%
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Dec 31 close.
Traded Mon, Nov 15. Filed Wed, Nov 17, 12:00 PM ET, during the session. Returns use the Nov 17 close and the Dec 31 close. Not investment advice.